Repligen (RGEN)

Repligen (RGEN) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• RGEN last traded at $173.40, -2.00% on the day.
• Repligen: market cap $11.23B, P/E -842.6, revenue $805.61M over the last four quarters.
• Over the past year RGEN returned 19.94%; year to date 5.82%.

Updated 2026-11-02 19:08 UTC